Intervention Protocol

Radioiodine therapy versus anti-thyroid medications for Graves' disease

  1. Chao Ma1,*,
  2. Jiawei Xie2,
  3. Hui Wang1,
  4. Jinsong Li1,
  5. Suyun Chen1

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 12 SEP 2012

DOI: 10.1002/14651858.CD010094


How to Cite

Ma C, Xie J, Wang H, Li J, Chen S. Radioiodine therapy versus anti-thyroid medications for Graves' disease (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD010094. DOI: 10.1002/14651858.CD010094.

Author Information

  1. 1

    Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University, Nuclear Medicine, Shanghai, Shanghai, China

  2. 2

    Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University, Stomatology, Shanghai, Shanghai, China

*Chao Ma, Nuclear Medicine, Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University, Kongjiang Road 1665, Shanghai, Shanghai, 200092, China. mc_7419@hotmail.com. ponymachao@163.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 SEP 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of radioiodine therapy versus anti-thyroid medications for Graves' disease.